Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The VICTORY Study: A Phase I Study of Venetoclax in Combination With Non-myeloablative Conditioning Allogeneic Haematopoietic Stem Cell Transplantation

NCT05005299 is registered in ClinicalTrials.gov with Melbourne Health as lead sponsor.

NCT NCT05005299
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05005299 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The VICTORY Study: A Phase I Study of Venetoclax in Combination With Non-myeloablative Conditioning Allogeneic Haematopoietic Stem Cell Transplantation
Lead sponsor
Melbourne Health
Phase
Phase 1
Overall status
Unknown status
Start date
June 8, 2022
Completion date
March 31, 2026
Enrollment
18 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, lymphoblastic, acute, l1, leukemia, lymphoblastic, acute, l2, leukemia, myeloid, acute, myelodysplastic syndromes, non-hodgkin lymphoma, plasma cell myeloma